Clinical Trial Update: PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating a PCSK9 inhibitor added to statin therapy for asymptomatic intracranial atherosclerosis and intracranial artery stenosis;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Plaque
• Intracranial Artery Stenosis
• Intracranial Atherosclerosis

Drugs mentioned

• PCSK9 inhibitor (PCSK9 inhibitor)
• Statin therapy (statin)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Intracranial Atherosclerosis, Intracranial Artery Stenosis | Phase 4 | Status: RECRUITING